Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

435

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

December 31, 2014

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

Pazopanib

Oral pazopanib tablet 800 mg once daily continuously

DRUG

placebo

matching placebo (800 mg tablet) once daily

Trial Locations (99)

24

GSK Investigational Site, Tallaght, Dublin

1007

GSK Investigational Site, Tunis

1008

GSK Investigational Site, Tunis

1130

GSK Investigational Site, Vienna

1590

GSK Investigational Site, Islamabad

1878

GSK Investigational Site, Quilmes

2065

GSK Investigational Site, St Leonards

2298

GSK Investigational Site, Waratah

3000

GSK Investigational Site, Sfax

3084

GSK Investigational Site, Heidelberg

3690

GSK Investigational Site, Wodonga

4000

GSK Investigational Site, San Miguel de Tucumán

4054

GSK Investigational Site, Sousse

4414

GSK Investigational Site, Palmerston North

5000

GSK Investigational Site, Córdoba

6002

GSK Investigational Site, Newtown, Wellington

7000

GSK Investigational Site, Hobart

8001

GSK Investigational Site, Christchurch

10043

GSK Investigational Site, Orbassano (TO)

11619

GSK Investigational Site, Tallinn

12808

GSK Investigational Site, Prague

20089

GSK Investigational Site, Rozzano (MI)

20132

GSK Investigational Site, Milan

26013

GSK Investigational Site, Crema

26500

GSK Investigational Site, Pátrai

26841

GSK Investigational Site, Casalpusterlengo (LO)

51014

GSK Investigational Site, Tartu

54600

GSK Investigational Site, Lahore

61037

GSK Investigational Site, Kharkiv

69600

GSK Investigational Site, Zaporizhzhya

74800

GSK Investigational Site, Karachi

79031

GSK Investigational Site, Lviv

83092

GSK Investigational Site, Donetsk

97500

GSK Investigational Site, Mérida

100034

GSK Investigational Site, Beijing

100853

GSK Investigational Site, Beijing

150054

GSK Investigational Site, Yaroslavl

198255

GSK Investigational Site, Saint Petersburg

394062

GSK Investigational Site, Voronezh

400026

GSK Investigational Site, Mumbai

420029

GSK Investigational Site, Kazan'

443066

GSK Investigational Site, Samara

454087

GSK Investigational Site, Chelyabinsk

500033

GSK Investigational Site, Hyderabad

560029

GSK Investigational Site, Bangalore

644013

GSK Investigational Site, Omsk

695011

GSK Investigational Site, Trivandrum

7500921

GSK Investigational Site, Santiago

7591046

GSK Investigational Site, Santiago

C1405CUB

GSK Investigational Site, Capital Federal

S2000KZE

GSK Investigational Site, Rosario

A-5020

GSK Investigational Site, Salzburg

A-1090

GSK Investigational Site, Vienna

A-1100

GSK Investigational Site, Vienna

30150-270

GSK Investigational Site, Belo Horizonte

90610 000

GSK Investigational Site, Porto Alegre

17210-120

GSK Investigational Site, Jaú

254-0364

GSK Investigational Site, Viña del Mar

656 53

GSK Investigational Site, Brno

430 12

GSK Investigational Site, Chomutov

708 52

GSK Investigational Site, Ostrava - Poruba

115 22

GSK Investigational Site, Athens

115 26

GSK Investigational Site, Athens

115 28

GSK Investigational Site, Athens

185 37

GSK Investigational Site, Athens

564 29

GSK Investigational Site, Thessaloniki

Unknown

GSK Investigational Site, Hong Kong

GSK Investigational Site, Kowloon

GSK Investigational Site, Tuen Mun, New Territories

GSK Investigational Site, Galway

411 004

GSK Investigational Site, Pune

00133

GSK Investigational Site, Rome

00152

GSK Investigational Site, Rome

LV 1002

GSK Investigational Site, Riga

LT-50009

GSK Investigational Site, Kaunas

LT-92228

GSK Investigational Site, Klaipėda

LT-08660

GSK Investigational Site, Vilnius

CP44280

GSK Investigational Site, Guadalajara

CP 14080

GSK Investigational Site, Mexico City

80-210

GSK Investigational Site, Gdansk

31-108

GSK Investigational Site, Krakow

31-115

GSK Investigational Site, Krakow

10-226

GSK Investigational Site, Olsztyn

10-228

GSK Investigational Site, Olsztyn

60-569

GSK Investigational Site, Poznan

00-909

GSK Investigational Site, Warsaw

115 478

GSK Investigational Site, Moscow

117 837

GSK Investigational Site, Moscow

129 128

GSK Investigational Site, Moscow

833 10

GSK Investigational Site, Bratislava

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Songpa-gu, Seoul

03115

GSK Investigational Site, Kyiv

EX2 5DW

GSK Investigational Site, Exeter

M20 4BX

GSK Investigational Site, Manchester

CH63 4JY

GSK Investigational Site, Bebington, Wirral

BT9 7AB

GSK Investigational Site, Belfast

SA2 8QA

GSK Investigational Site, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY